- Analysts
- Dividend Payments
- Government Awards
- Insiders
- Lobbying Expenses
- Segment Revenues
- Shareholder Structure
- Supply / Portfolio
- Valuation Models [Soon]
- Board & Officers
- Business Intelligence
- Employee Voice
- ESG Scores [Soon]
- Mergers and Acquisitions
- Qualified Risks
- Clinical Trials [Soon]
- H1B/PERM Strategy
- Industry H&T [Soon]
- Macro
- News
- Patents / Trademarks [Soon]
- Peer Performance
- Relevant Disputes [Soon]
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…
Shareholders
Major Shareholders · StructureBreakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public. for Fresh Tracks Therapeutics, Inc.
Beneficial Owners Beta
Beneficial owners who control a significant portion of the shares outstanding.
Owner | Shares | Equivalence - $0.66 per share | Last Form/Filing | Last Transaction |
---|---|---|---|---|
10% Holder | ||||
Exploration Capital, Llc
Uncategorized SEC Entity
|
1,739,412 | $1,148,011.92 | ||
Officers/Directors Below 10% | ||||
Internal : VP of Finance & CAO
|
0 | $0 |
S
74 x $0.91 =
$67.34
|
|
Internal : CEO and CFO
|
0 | $0 |
|
|
Internal : Former Chief R&D Officer & COO
|
0 | $0 |
|
|
Internal : President and CEO
|
0 | $0 |
|
|
Internal : Gen Counsel, CCO, & Secretary
|
128,879 | $85,060.14 |
P
18,124 x $0.67 =
$12,143.08
|
|
Internal : CHAIRMAN OF THE BOARD
|
448,411 | $295,951.26 |
P
100,000 x $0.67 =
$67,000.00
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Director
|
0 | $0 |
|
|
Internal : Chief Accounting Officer
|
0 | $0 |
|
|
Internal : Chief Medical Officer
|
0 | $0 |
|
|
Internal : Chief Executive Officer
|
0 | $0 |
|
Shareholder Breakdown
The breakdown presents the total weighting of the relevant parties: Institutes, Insiders & Public.
It's perfect to get a quick briefing regarding the shareholder structure of Fresh Tracks Therapeutics, Inc.
Short
We source Fail-To-Deliver data every month, directly from the SEC.